Human IL-18 R beta/IL-1 R7 Antibody, R&D Systems™

IL-18 R beta/IL-1 R7/ACPL

Monoclonal

LYOPH

Western Blot 1 ug/mL, Neutralization 0.3-1 ug/mL

O95256

IL18RAP

Mouse myeloma cell line NS0-derived recombinant human IL-18 R beta/IL-1 R7 Met1-Arg356 Accession # O95256

25 μg

Primary

Detects human IL-18 R beta/IL-1 R7 in direct ELISAs and Western blots. In direct ELISAs and Western blots, less than 1% cross-reactivity with recombinant mouse IL-18 R beta , recombinant human (rh) IL-18 R, rhIL-1 RI, rhIL-1 RII, rhIL-1 RAcP, and rhIL-1 Rrp2 is observed.

Human

Purified

Western Blot, Neutralization

132016

Unconjugated

Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative

Accessory protein-like, AcPL, CD218 antigen-like family member B, CD218b, CD218b antigen, CDw218b, IL-1 R7, IL-18 receptor accessory protein, IL-18 receptor beta, IL18R beta, IL-18RAcP, IL18RAP, IL-18Rb, IL18RB, IL-18Rbeta, IL-18R-beta, IL-1R accessory protein-like, IL1R7, IL-1R7, IL-1R-7, IL-1RAcPL, interleukin 18 receptor accessory protein, Interleukin-1 receptor 7, interleukin-18 receptor accessory protein, Interleukin-18 receptor accessory protein-like, Interleukin-18 receptor beta, MGC120589, MGC120590

Mouse

Protein A or G purified from hybridoma culture supernatant

RUO

8807

Reconstitute at 0.5 mg/mL in sterile PBS.

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.

IgG1